The global neoantigen cancer vaccine market size was valued at USD 377.53 million in 2024 and is projected to grow from USD 434.16 million in 2025 to USD 1328.10 million by 2033, growing at a CAGR of 15% during the forecast period (2025–2033). https://straitsresearch.com/report/neoantigen-cancer-vaccine-market